{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:44:17Z","timestamp":1782135857656,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010794","name":"Medicinska fakulteten, Ume\u00e5 Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004885","name":"Ume\u00e5 Universitet","doi-asserted-by":"publisher","award":["LP 21-2280"],"award-info":[{"award-number":["LP 21-2280"]}],"id":[{"id":"10.13039\/501100004885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004885","name":"Ume\u00e5 Universitet","doi-asserted-by":"publisher","award":["LP 23-2343"],"award-info":[{"award-number":["LP 23-2343"]}],"id":[{"id":"10.13039\/501100004885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004886","name":"Cancer Research Foundation in Northern Sweden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ajog.2023.09.094","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T02:01:36Z","timestamp":1695952896000},"page":"75.e1-75.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1288-4645","authenticated-orcid":false,"given":"Sarah","family":"Jonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"H\u00e4ggstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Idahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.09.094_bib1","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.09.094_bib2","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian cancer","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2023.09.094_bib3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajog.2023.09.094_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.canep.2018.05.011","article-title":"Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer","volume":"55","author":"Stewart","year":"2018","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.ajog.2023.09.094_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1055-9965.EPI-16-0459","article-title":"Is pelvic inflammatory disease a risk factor for ovarian cancer?","volume":"26","author":"Rasmussen","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2023.09.094_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2020.02.002","article-title":"Association between pelvic inflammatory disease and risk of ovarian cancer: an updated meta-analysis","volume":"157","author":"Piao","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2023.09.094_bib7","first-page":"667","article-title":"Pelvic inflammatory disease and risk of ovarian cancer","volume":"5","author":"Parazzini","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ajog.2023.09.094_bib8","first-page":"1459","article-title":"Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors","volume":"24","author":"Rasmussen","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ajog.2023.09.094_bib9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/IGC.0000000000000235","article-title":"Pelvic inflammation and the pathogenesis of ovarian cancer: a cohort study","volume":"24","author":"McAlpine","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ajog.2023.09.094_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1186\/s12885-016-2857-1","article-title":"Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study","volume":"16","author":"Shen","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajog.2023.09.094_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: a pooled analysis of 13 case-control studies","volume":"185","author":"Rasmussen","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajog.2023.09.094_bib12","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ajog.2023.09.094_bib13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/ijc.33714","article-title":"Risk of epithelial ovarian cancer Type I and II after hysterectomy, salpingectomy and tubal ligation-a nationwide case-control study","volume":"149","author":"Darelius","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.09.094_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2020.11.046","article-title":"Association between pelvic inflammatory disease and subsequent salpingectomy on the risk for ovarian cancer","volume":"145","author":"Falconer","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2023.09.094_bib15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2023.09.094_bib16","first-page":"349","article-title":"The effect of breastfeeding duration and parity on the risk of epithelial ovarian cancer: a systematic review and meta-analysis","volume":"49","author":"Sung","year":"2016","journal-title":"J\u00a0Prev Med Public Health"},{"key":"10.1016\/j.ajog.2023.09.094_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.09.094_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jnci\/djad011","article-title":"Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis","volume":"115","author":"Fu","year":"2023","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2023.09.094_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00003081-200103000-00010","article-title":"Oral contraceptives: current status","volume":"44","author":"Burkman","year":"2001","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.09.094_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10654-009-9350-y","article-title":"The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research","volume":"24","author":"Ludvigsson","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ajog.2023.09.094_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ajog.2023.09.094_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ijc.23017","article-title":"Australian Cancer Study (Ovarian Cancer), Australian Ovarian Cancer Study Group. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer","volume":"122","author":"Merritt","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.09.094_bib23","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ijc.32999","article-title":"Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: results from the EPIC cohort","volume":"147","author":"Idahl","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajog.2023.09.094_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djy084","article-title":"Antibodies against Chlamydia trachomatis and ovarian cancer risk in two independent populations","volume":"111","author":"Trabert","year":"2019","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2023.09.094_bib25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41416-019-0422-9","article-title":"Sexually transmitted infections and risk of epithelial ovarian cancer: results from the Nurses\u2019 Health Studies","volume":"120","author":"Fortner","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajog.2023.09.094_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.chom.2013.05.010","article-title":"Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response","volume":"13","author":"Chumduri","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ajog.2023.09.094_bib27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.187.4.487","article-title":"Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation","volume":"187","author":"Fan","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.ajog.2023.09.094_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106056","article-title":"Pgp3 protein of Chlamydia trachomatis inhibits apoptosis via HO-1 upregulation mediated by PI3K\/Akt activation","volume":"178","author":"Shu","year":"2023","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ajog.2023.09.094_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ajog.2023.09.094_bib31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/0284186X.2017.1366048","article-title":"Data quality in the Swedish Quality Register of Gynecologic Cancer\u2014a Swedish Gynecologic Cancer Group (SweGCG) study","volume":"57","author":"Rosenberg","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ajog.2023.09.094_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ajog.2023.09.094_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-59745-423-0_10","article-title":"The Swedish multi-generation register","volume":"675","author":"Ekbom","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ajog.2023.09.094_bib35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ajog.2023.09.094_bib37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2023.09.094_bib38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bcpt.12613","article-title":"The first decade with the Swedish prescribed drug register - a systematic review of the output in the scientific literature","volume":"119","author":"Wallerstedt","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.ajog.2023.09.094_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/bmb\/ldm001","article-title":"Measuring socioeconomic position in health research","volume":"81\u201382","author":"Galobardes","year":"2007","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ajog.2023.09.094_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s-10508-005-1799-5","article-title":"Assessment of sexual behavior, sexual attitudes, and sexual risk in Sweden (1989-2003)","volume":"34","author":"Herlitz","year":"2005","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.ajog.2023.09.094_bib41","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/pds.1635","article-title":"Education and drug use in Sweden\u2014a nationwide register-based study","volume":"17","author":"Weitoft","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:44:24Z","timestamp":1757591064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823007238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0002937823007238"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.09.094","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.09.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}